How Did Jim Cramer’s 12 Bold Predictions Play Out?

1. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund holders: 66

Abbott Laboratories (NYSE:ABT), the global healthcare company known for its diabetes care products and medical devices, was brought up by Cramer in that older episode while discussing the ripple effects of GLP-1 weight-loss drugs. At the time, he countered prevailing concerns that Abbott’s diabetes business would be negatively affected by these treatments. Here’s his analysis:

“We heard that Abbott’s diabetes management franchise will be hurt by GLP-1s but the company has seen no decline in sales from this new class of drugs. Again, Abbott says they’re complimentary. They’re doing even better, and in fact, the GLP-1s have helped sales of the blood sugar monitors because people want to know how this stuff-  whether it’s working. Plus, they’re selling protein shakes to help offset the muscle you lose when you take Lil’s weight loss drug.”

Jim Cramer was right to be optimistic about Abbott Laboratories (NYSE:ABT) back then, as the stock has risen by 21.66% since.

Cramer also recently discussed the company’s strong earnings report, applauding the CEO’s leadership. Here’s what he said on April 16:

“By the way, can we just be sure Abbott did not miss. That’s a COVID test that’s coming down. And Abbott is the first one that I’m beginning to see.  […]

Dollar weakness coming. It’s going to help them. Where do they build their factories? In the United States. For the United States. Overseas. For overseas. David, they are on fire when it comes to so many different line items, including heart. Diagnostics are pretty good. Baby food, if they continue to have a problem with it.

I’ve got to tell you with some of that stuff that they’re doing with that lawsuit, they’re not going to just sit there and take it. I thought that Robert Ford did a remarkable job. Tour de force quarter, people should listen to how you can raise numbers. Do it right. By the way, they kept numbers flat, but raised numbers on a weak dollar. And I just am just amazed at how good they are. That’s a Miles White legacy, Robert Ford keeping it going. The only week this was because of the COVID, the test you can still get. What a quarter.”

ABT is a stock Jim Cramer recently discussed. While we acknowledge the potential of ABT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ABT but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.